Related Experiment Videos
[Advances and risks in estrogen therapy in the perimenopause]
Wiener Klinische Wochenschrift
|October 28, 1983
Summary
Perimenopausal oestrogen therapy effectively manages bleeding and mood disturbances. When administered correctly, it offers significant benefits for osteoporosis and genitourinary symptoms without increasing risks of thrombosis or myocardial infarction.
Area of Science:
- Endocrinology
- Gynecology
- Pharmacology
Context:
- Perimenopause presents challenges including dysfunctional uterine bleeding, mood disturbances, and atrophic changes.
- Subjective symptoms like sweating, dizziness, nervousness, and concentration difficulties are common.
Purpose:
- To evaluate the therapeutic benefits of oestrogen treatment during perimenopause.
- To assess the safety profile of oestrogen therapy, including risks of thrombosis, embolism, and myocardial infarction.
- To investigate the controversy surrounding endometrial carcinoma incidence.
Summary:
- Oestrogen therapy in perimenopause effectively regulates uterine bleeding and improves subjective symptoms such as sweating, dizziness, nervousness, and concentration.
- It is particularly successful in treating reactive depression and insomnia, and beneficial for atrophic genital changes and urge incontinence.
- Natural oestrogens in usual doses do not appear to increase weight, blood pressure, coagulation changes, thrombosis, embolism, or myocardial infarction incidence.
Impact:
- Oestrogen therapy demonstrates significant socio-medical importance in combating postmenopausal osteoporosis.
- Concerns regarding endometrial carcinoma may stem from incorrect administration protocols, including excess dosage, continuous therapy, and lack of progestational agents.
- Proper administration, considering contraindications and risk factors, is crucial for safe and effective oestrogen therapy.